Single-active enteric functional pellet designed for oxygen and moisture sensitivity and gastric exposure. 20% w/w NADH; enteric / intestinal.
Technical summary
Product code NG-PEL-001
Choose an evaluation sample or listed pack where available. Use Request a Quotation for commercial supply and Request Technical Documents for controlled product information.
For business buyers. Product-specific documentation and availability are confirmed for each enquiry.
How the sample programme worksProduct information
Review the key specifications at a glance, then expand only the sections you need.
Single-active enteric functional pellet designed for oxygen and moisture sensitivity and gastric exposure. 20% w/w NADH; enteric / intestinal.
NADH Enteric-Protected Pellets 20% w/w supplies Reduced nicotinamide adenine dinucleotide (NADH) in a multi-unit functional pellet with a product-specific food-grade coating system. It is intended as an independent formulation module for professional B2B use. Product-specific identity, assay, physical, microbiological, contaminant and stability controls are defined in the finished-product specification and verified by batch CoA.
NADH Enteric-Protected Pellets 20% w/w supplies Reduced nicotinamide adenine dinucleotide (NADH) at 20% w/w NADH in a multi-unit functional pellet with a product-specific food-grade coating system; its release behaviour is Enteric / intestinal.
| Product ID / order SKU | NG-PEL-001 |
|---|---|
| Technology | Functional Pellets |
| Product type | Enteric Functional Pellet |
| Current status | Qualification and availability confirmed per enquiry |
| Active / marker | Reduced nicotinamide adenine dinucleotide (NADH) |
| Assay / loading | 20% w/w NADH |
| Delivery system | multi-unit functional pellet with a product-specific food-grade coating system |
| Release type | Enteric / intestinal |
| Evaluation sample | 50 g — €60 ex VAT |
| Commercial MOQ | Confirmed per quotation |
| Pack sizes | 1 kg; 5 kg; 25 kg |
| Lead time | Confirmed per quotation |
The key public specification is 20% w/w NADH with Enteric / intestinal release behaviour; batch acceptance follows the approved product-specific specification and analytical method.
| Active ingredient | NADH |
|---|---|
| Chemical / nutrient form | Reduced nicotinamide adenine dinucleotide (NADH) |
| Assay / loading | 20% w/w NADH |
| Assay method | Approved product-specific analytical method |
| Carrier / wall material | Food-grade pellet core, binder and product-specific functional coating |
| Delivery system | multi-unit functional pellet with a product-specific food-grade coating system |
| Release behaviour | Enteric / intestinal |
| Particle size d10 | Per specification |
| Particle size d50 | Per specification |
| Particle size d90 | Per specification |
| Mesh range | 500–850 µm target; controlled specification governs |
| Bulk density | Per specification |
| Tapped density | Per specification |
| Moisture / loss on drying | Per specification |
| Water activity | Per specification |
| Solubility | Product-specific; see TDS |
| Dispersibility | Product-specific; see TDS |
| Flowability | Per finished-product specification |
| Appearance / colour | Product-specific; see TDS |
| Odour | Product-specific; see TDS |
| Taste | Product-specific; see TDS |
| pH | Not applicable unless specified |
| Microbiological limits | Per finished-product microbiological specification |
| Heavy-metals limits | Per finished-product heavy-metals specification |
| Residual solvents | Complies with finished-product specification |
| Oxidation markers | Product-specific oxidation or degradation markers per finished specification |
| Other critical specification | Dissolution/release profile, coating integrity and friability |
| Shelf life | Per current stability documentation |
The public composition identifies NADH with a Food-grade pellet core, binder and product-specific functional coating; exact proprietary excipient ratios and supplier details remain controlled.
| Component | Function | Public composition information |
|---|---|---|
| NADH | Active ingredient | Product-specific qualified source; 20% w/w NADH; Finished-product specification |
| Food-grade pellet core / binder system | Pellet formation and mechanical integrity | Qualified food-grade source; q.s.; Controlled composition; exact proprietary composition is confidential |
| Product-specific functional coating system | Gastric resistance and intestinal release | Qualified food-grade source; q.s. to 100%; Controlled composition; exact proprietary composition is confidential |
Country of origin is stated in the controlled Country of Origin Statement. Supplier and manufacturing-site information are not published.
A multi-unit pellet architecture separates the active from the formulation environment and delivers the defined enteric / intestinal behaviour.
This ingredient is best suited to hard capsules and multi-unit pellet systems.
Performance is verified using approved product-specific methods and the controlled evidence listed below.
| Test / study | Result summary | Evidence |
|---|---|---|
| Identity and assay confirmation | Conforms to approved specification | Current commercial batch; Batch CoA |
| Dissolution / release profile | Conforms to approved dissolution / release criteria | Representative batch; Dissolution / Release Data |
| Stability / shelf-life support | Meets approved stability criteria through the documented period | Representative stability batches; Stability Documentation |
Store tightly closed in original packaging in a cool, dry place, protected from heat, moisture and direct light. Free-flowing multi-unit pellets; colour and odour are product-specific. Avoid coating damage during handling.
The current product-specific document set is confirmed for each enquiry according to qualification status, the applicable manufacturer and relevant batch. Controlled composition, characterisation or performance details may require an NDA where specified.
Regulatory suitability depends on the intended use, dose and target market; the customer must confirm finished-product compliance.
| Target market | European Union / EEA |
|---|---|
| Intended use | Food supplements and professional formulation use; final suitability depends on dose and application |
| Ingredient legal status | Product-specific ingredient-level information can be confirmed; the customer must verify intended use and national requirements |
| Novel food review | Product-specific regulatory-status information is confirmed on request |
| Carrier / additive compliance | All carriers, wall materials and coating components reviewed for the intended product scope |
| Maximum / recommended use level | Set by customer formulation, applicable law and product-specific technical guidance |
| Label declaration | NADH |
| Allergen declaration | Declare according to the current product-specific allergen statement |
| Origin declaration | See Country of Origin Statement |
| Nutrition / health claim relevance | Finished-product nutrition or health claims are the customer’s responsibility |
| Technical claim / statement | Functional pellet with defined enteric / intestinal performance. |
| Evidence supporting statement | TDS, specification, stability and dissolution/release data |
| Medicinal / disease wording check | Passed: no medicinal or disease-treatment wording |
| Regulatory approval status | Ready for product-specific website approval |
No medicinal, disease-treatment or finished-product health claim is made. The stated release or protection function applies only when pellet integrity is maintained and the finished dosage form is validated. Finished-product classification, dose, permitted use, label declarations, nutrition or health claims and market compliance remain the customer’s responsibility.
The current product-specific document set is confirmed on request according to qualification status, the applicable manufacturer and relevant batch. Where available, product-specific dissolution or release data support the stated pellet function.
Yes. This product may be combined with other independent NexaGens formulation modules after compatibility and finished-product validation.
The release format is enteric / intestinal.
For professional B2B food, food-supplement and formulation use only. Not for direct consumer use.
Request the current technical, quality, stability and compliance documents for this ingredient.
Review the formulation challenges most relevant to this ingredient before requesting evaluation material or documentation.
View all functional pellets